A review of antipsychotics in the treatment of obsessive compulsive disorder
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Original article can be found at: http://jop.sagepub.com/ Copyright British Association for Psychopharmacology. DOI: 10.1177/0269881105056640 [Full text of this article is not available in the UHRA]
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Mataix-Cols, D., Rauch, S. L., Manzo, P. A., Jenike, M. A., & Baer, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1409 · Cited by 716 · cited 1×
“Mataix-Cols et al. (1999) suggest that adults with compulsive rituals, early-onset, longer illness duration, chronic course and presence of comorbid tics and personality disorders (specifically schizotypal) do not respond well.”
BackgroundMcDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Treatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Marek, G. J., Carpenter, L. L., McDougle, C. J., & Price, L. H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300057 · Cited by 275
Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220 · cited 2×
“Weight gain has been reported in shortterm trials of olanzapine (Bystritsy et al., 2004; Shapira et al., 2004) and drowsiness in trials of olanzapine (Bystritsky et al., 2004) and quetiapine (Fineberg et al., 2005).”
ResultSaxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210
Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197 · cited 3×
“A smaller double-blind study by Hollander et al. (2003a) examined patients failing to respond to at least 2 trials of SRIs using an intent-to-treat analysis.”
BackgroundLow level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
Denys, D., van der Wee, N., Janssen, J., De Geus, F., & Westenberg, H. G. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.023 · Cited by 195
Cited by
Role of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder
Koo, M.-S., Kim, E.-J., Roh, D., & Kim, C.-H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.148 · Cited by 125
Muscatello, M. R. A., Bruno, A., Pandolfo, G., Micò, U., Scimeca, G., Romeo, V. M., Santoro, V., Settineri, S., Spina, E., & Zoccali, R. A. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820e3db6 · Cited by 122
“Notwithstanding, negative results were reported for risperidone,(20) olanzapine,(21) and quetiapine.(22,23) Antipsychotic augmentation in treatment-resistant OCD is yet well supported by meta-analysis(9,24,25) and by recent reviews,(7,8,10,23,26,27) which tend to confirm the efficacy of this treatment strategy, also p…”
ResultFineberg, N. A., Stein, D. J., Premkumar, P., Carey, P., Sivakumaran, T., Vythilingum, B., Seedat, S., Westenberg, H., & Denys, D. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000215083.57801.11 · Cited by 103
“Reports on placebo-controlled studies of SRI augmentation using haloperidol, risperidone, olanzapine and quetiapine support further exploration of the efficacy of this approach in resistant OCD, although negative and positive findings have been reported (Fineberg et al., 2006).”
BackgroundSelf-citationBruno, A., Micò, U., Pandolfo, G., Mallamace, D., Abenavoli, E., Di Nardo, F., D’Arrigo, C., Spina, E., Zoccali, R. A., & Muscatello, M. R. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431751 · Cited by 103
Albert, U., Marazziti, D., Di Salvo, G., Solia, F., Rosso, G., & Maina, G. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666171222163645 · Cited by 90
Metadata
- Authors
- Fineberg, N. A., Gale, T. M., & Sivakumaran, T.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-01
- Volume
- 20
- Issue
- 1
- Pages
- 97-103
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2025392264
- Cited by
- 62
- References
- 14
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of antipsychotics in the treatment of obsessive compulsive disorder. https://app.cochat.ai/papers/10.1177/0269881105056640
- The paper
- Fineberg, N. A., Gale, T. M., & Sivakumaran, T. (2006). A review of antipsychotics in the treatment of obsessive compulsive disorder. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105056640
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.